Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL)

被引:40
|
作者
Sasayama, Takashi [1 ]
Tanaka, Kazuhiro [1 ]
Mizowaki, Takashi [1 ]
Nagashima, Hiroaki [1 ]
Nakamizo, Satoshi [1 ]
Tanaka, Hirotomo [1 ]
Nishihara, Masamitsu [2 ]
Mizukawa, Katsu [1 ]
Hirose, Takanori [3 ]
Itoh, Tomoo [4 ]
Kohmura, Eiji [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo, Japan
[2] Nishi Kobe Med Ctr, Dept Neurosurg, Kobe, Hyogo, Japan
[3] Kobe Univ Hosp, Dept Pathol Reg Commun, Kobe, Hyogo, Japan
[4] Kobe Univ Hosp, Diagnost Pathol, Kobe, Hyogo, Japan
关键词
cerebrospinal fluid; IL-10; primary central nervous system lymphoma; prognosis; tumor-associated macrophage; POOR-PROGNOSIS; SCAVENGER RECEPTOR; CELL LYMPHOMA; PROGRESSION; EXPRESSION; STAT3; INFILTRATION; SUPPRESSION; ACTIVATION; DIVERSITY;
D O I
10.1111/bpa.12318
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Increased tumor-associated macrophages (TAMs) have been reported to be associated with poor prognosis in various tumors; however, the importance of TAMs in primary central nervous system lymphoma (PCNSL) has not been clarified. In 47 patients with PCNSL who were treated with high-dose methotrexate (MTX) and radiotherapy, the relationships between the infiltration levels of TAMs and the clinicopathological parameters were analyzed. Univariate analysis of the Cox proportional hazards model using continuous scales revealed that increased CD68 positive (+) TAMs was significantly associated with inferior progression-free survival (PFS) (P=0.04), and trends were observed for the increased CD163(+)TAMs and having shorter PFS (P=0.05). However, increased TAMs were not associated with overall survival. Because TAMs are known to produce various cytokines, we examined the relationships between cerebrospinal fluid (CSF) cytokines and TAMs. CSF interleukin-6 (IL-6) and soluble IL-2 receptor were not correlated with the infiltration rate of TAMs; however, CSF IL-10 level was correlated with infiltration levels of CD68 and CD163(+)TAMs. We also confirmed the expression of IL-10 in CD68(+)and CD163(+)TAMs by double immunostaining analysis. Our results indicate that a high level of IL-10 in CSF may be positively associated with the infiltration level of TAMs in PCNSLs.
引用
收藏
页码:479 / 487
页数:9
相关论文
共 50 条
  • [21] Angiogenesis in primary central nervous system lymphoma (PCNSL)
    Hiroaki Takeuchi
    Ken Matsuda
    Ryuhei Kitai
    Kazufumi Sato
    Toshihiko Kubota
    Journal of Neuro-Oncology, 2007, 84 : 141 - 145
  • [22] The interleukin-10 in the central nervous system
    Kurowska, Ewelina
    Majkutewicz, Irena
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 : 886 - 891
  • [23] Angiogenesis in primary central nervous system lymphoma (PCNSL)
    Takeuchi, Hiroaki
    Matsuda, Ken
    Kitai, Ryuhei
    Sato, Kazufumi
    Kubota, Toshihiko
    JOURNAL OF NEURO-ONCOLOGY, 2007, 84 (02) : 141 - 145
  • [24] Cerebrospinal Fluid Interleukin-10 Biomarker for Vitreoretinal Lymphoma
    Zhang, Xiao
    Zhang, Yan
    Zhuang, Zhe
    Zhao, Chan
    Gao, Fei
    Dai, Rong-Ping
    Yu, Wei-Hong
    Chen, You-Xin
    Zhang, Wei
    Zhang, Mei-fen
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2023, 246 : 242 - 250
  • [25] CXCL13 AND IL-10 IN CEREBROSPINAL FLUID (CSF) AS AN IMPORTANT BIOMARKER FOR PRIMARY CENTRAL NERVOUS SYSTEM CELL LYMPHOMA (PCNSL)
    Sasayama, Takashi
    Tanaka, Kazuhiro
    Nishihara, Masamitsu
    Nagashima, Hiroaki
    Mizukawa, Katsu
    Sakata, Junichi
    Maeyama, Masahiro
    Kohmura, Eiji
    NEURO-ONCOLOGY, 2016, 18 : 111 - 111
  • [26] Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma
    Sun, Xiaoqing
    Wang, Caiqin
    Chen, Cui
    Huang, Jiajia
    Wu, Xianqiu
    Wang, Yu
    He, Xiaohua
    Cao, Jianghua
    Jiang, Wenqi
    Sun, Peng
    Li, Zhiming
    HEMATOLOGICAL ONCOLOGY, 2021, 39 (05) : 625 - 638
  • [27] Primary central nervous system lymphoma (PCNSL) in older patients
    Bertucci, Alexandre
    Harlay, Vincent
    Chinot, Olivier
    Tabouret, Emeline
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (05) : 373 - 381
  • [28] Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL)
    Nelson, DF
    JOURNAL OF NEURO-ONCOLOGY, 1999, 43 (03) : 241 - 247
  • [29] Primary central nervous system lymphoma (PCNSL) occurring in pregnancy
    O'Mahony, D
    Razak, ARA
    Brett, F
    Grogan, L
    JOURNAL OF NEUROLOGY, 2005, 252 (09) : 1133 - 1134
  • [30] LATE RELAPSE IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL)
    Nayak, Lakshmi
    Ladanyi, Marc
    Hedvat, Cyrus
    Abrey, Lauren E.
    DeAngelis, Lisa M.
    NEURO-ONCOLOGY, 2009, 11 (05) : 625 - 625